World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00963625
Date of registration: 19/08/2009
Primary sponsor: Fertility Center of Las Vegas
Public title: Comparison of Transfers of Fresh and Thawed Embryos in Normal Responder Patients
Scientific title: Comparison of Transfers of Fresh and Thawed Embryos in Normal Responder Patients
Date of first enrolment: October 2007
Target sample size: 100
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00963625
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Bruce Shapiro, M.D., Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Fertility Center of Las Vegas
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female patient 18 to 40 years of age seeking their first IVF treatment.

- Cycle day 3 FSH less than 10.0 IU/l.

- 8 to 15 antral follicles observed on ultrasound.

Exclusion Criteria:

- Failure to follow the protocol.

- Embryo biopsy.

- Any prior IVF cycle(s).



Age minimum: 18 Years
Age maximum: 40 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Infertility
Intervention(s)
Procedure: Embryo cryopreservation
Procedure: Fresh blastocyst transfer
Primary Outcome(s)
Clinical pregnancy (fetal heartbeat observed on ultrasound at 7 weeks gestation) [Time Frame: 7 weeks gestation]
Secondary Outcome(s)
Implantation rate (ratio of the number of fetal heart tones to the number of transferred blastocysts) [Time Frame: 7 weeks gestation]
Ongoing pregnancy at 10 weeks gestation [Time Frame: 10 weeks gestation]
Secondary ID(s)
SAIRB 07-0014
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ferring Pharmaceuticals
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history